Cargando…

Isolated prostate amyloidosis; a case report

Identification of amyloidosis on a prostate biopsy specimen raises suspicion for systemic amyloidosis. For patients at risk of prostate adenocarcinoma, a transrectal MRI ultrasound fusion (MRI-TRUS) guided biopsy of the prostate is often needed for further investigation. Our patient is a 70 year old...

Descripción completa

Detalles Bibliográficos
Autores principales: Sibley, Robert R., Ellison, Benjamin, Siegert, James J., Van Gorder, Mark A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508406/
https://www.ncbi.nlm.nih.gov/pubmed/36164377
http://dx.doi.org/10.1016/j.eucr.2022.102229
_version_ 1784797011116032000
author Sibley, Robert R.
Ellison, Benjamin
Siegert, James J.
Van Gorder, Mark A.
author_facet Sibley, Robert R.
Ellison, Benjamin
Siegert, James J.
Van Gorder, Mark A.
author_sort Sibley, Robert R.
collection PubMed
description Identification of amyloidosis on a prostate biopsy specimen raises suspicion for systemic amyloidosis. For patients at risk of prostate adenocarcinoma, a transrectal MRI ultrasound fusion (MRI-TRUS) guided biopsy of the prostate is often needed for further investigation. Our patient is a 70 year old male presenting from his primary care provider with an elevated PSA. The patient underwent MRI-TRUS fusion biopsy of the prostate, which demonstrated AL (lambda)-type amyloidosis, confirmed by mass spectrometry in addition to prostatic adenocarcinoma. He was subsequently diagnosed with primary amyloidosis of the prostate without evidence of other amyloid deposition sites.
format Online
Article
Text
id pubmed-9508406
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-95084062022-09-25 Isolated prostate amyloidosis; a case report Sibley, Robert R. Ellison, Benjamin Siegert, James J. Van Gorder, Mark A. Urol Case Rep Oncology Identification of amyloidosis on a prostate biopsy specimen raises suspicion for systemic amyloidosis. For patients at risk of prostate adenocarcinoma, a transrectal MRI ultrasound fusion (MRI-TRUS) guided biopsy of the prostate is often needed for further investigation. Our patient is a 70 year old male presenting from his primary care provider with an elevated PSA. The patient underwent MRI-TRUS fusion biopsy of the prostate, which demonstrated AL (lambda)-type amyloidosis, confirmed by mass spectrometry in addition to prostatic adenocarcinoma. He was subsequently diagnosed with primary amyloidosis of the prostate without evidence of other amyloid deposition sites. Elsevier 2022-09-16 /pmc/articles/PMC9508406/ /pubmed/36164377 http://dx.doi.org/10.1016/j.eucr.2022.102229 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Oncology
Sibley, Robert R.
Ellison, Benjamin
Siegert, James J.
Van Gorder, Mark A.
Isolated prostate amyloidosis; a case report
title Isolated prostate amyloidosis; a case report
title_full Isolated prostate amyloidosis; a case report
title_fullStr Isolated prostate amyloidosis; a case report
title_full_unstemmed Isolated prostate amyloidosis; a case report
title_short Isolated prostate amyloidosis; a case report
title_sort isolated prostate amyloidosis; a case report
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508406/
https://www.ncbi.nlm.nih.gov/pubmed/36164377
http://dx.doi.org/10.1016/j.eucr.2022.102229
work_keys_str_mv AT sibleyrobertr isolatedprostateamyloidosisacasereport
AT ellisonbenjamin isolatedprostateamyloidosisacasereport
AT siegertjamesj isolatedprostateamyloidosisacasereport
AT vangordermarka isolatedprostateamyloidosisacasereport